Clinical Trial Update: Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of sunitinib in patients with advanced gastric cancer previously treated with FOLFIRI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: PD Dr Markus Möhler | Conditions: Adenocarcinoma | Phase 2 | Status: COMPLETED